On Friday, Shares of eBay Inc (NASDAQ:EBAY), added 1.86% and closed at $32.90 in the last trading session. The last trading range of the stock ranges between $32.46 and $33.02. With mobile becoming an integral part of the event experience, StubHub recently declared the first ticketing app for Apple TV. Designed to be purposefully different from its core mobile app experiences, the new StubHub app for Apple TV is less transactional and more emotional – and encourages people to browse and discover events nearby or in a city across the U.S.
Specially designed for 4th gen Apple TV, the new StubHub app builds on the theory that the best screen is life-size. It takes advantage of a large-format TV screen to showcase event imagery and an energetic, highly visual design aesthetic within StubHub’s new, dynamic brand look and feel.
In creating this design aesthetic, StubHub’s designers and engineers had to consider new use cases for Apple TV and design for the person who isn’t sure what they want to do, or who needs extra motivation to get out of the house. The design was tested and iterated through several rounds of user feedback, in which StubHub designers added the side-scroll interface for browsing within a seating section of a specific event, and included high-resolution seat maps on the listing cards so consumers could get a clear idea of the view from the section in which they were considering tickets.
“We know that most people will be interacting with our app from their couch, as they’re looking for something to do, so we kept the StubHub app for Apple TV focused on browsability and discovery, to better motivate people to get up and get out,” said Marcus Shelksohn, director of mobile product. “The StubHub design team wanted to create a more custom interface to reflect the emotional nature of event discovery – and the result is an engaging look and feel that maximizes event imagery and seat maps, and is highly intuitive to navigate.”
Exelixis, Inc. (NASDAQ:EXEL), jumped 4.15% and closed at $12.79 in the last trading session. The last trading range of the stock ranges between $12.13 and $121.99. The company’s Market capitalization is $3.07 Billion with the total Outstanding Shares of 230.33 million. Exelixis, Inc. (EXEL) recently declared that accomplished biopharmaceutical executive Julie Anne Smith has been elected to the company’s Board of Directors. Ms. Smith’s appointment took effect on September 22, 2016.
Ms. Smith has nearly two decades of operational leadership experience in high growth public, private, startup, and established biopharmaceutical businesses. She presently serves as president and chief executive officer of Raptor Pharmaceuticals, a commercial-stage, global innovator in the development and commercialization of orphan disease therapies. Ms. Smith formerly held key commercial and planned leadership positions at companies counting Enobia Pharma, Jazz Pharmaceuticals, and Genzyme.
“I’m delighted to welcome Julie Anne Smith to the Exelixis board of directors,” said Stelios Papadopoulos, Ph.D., an Exelixis-co-founder and chairman of the company’s board. “Her deep commercial expertise will serve Exelixis well as the company continues to execute on the launch of its most recent therapy, CABOMETYX, following regulatory approval in the United States earlier this year.”